Fabrazyme and condition aggravated Patient Reports February 11, 2012

Fabrazyme Side Effects Report #5792525-1
Fabrazyme side effect was reported by a Physician from JAPAN on June 10, 2008. Male patient, 83 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, cardiac failure congestive, cardiac hypertrophy, cholestasis, condition aggravated, disease recurrence. Fabrazyme dosage: 45 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ASPIRIN, ACETAMINOPHEN, PIMOBENDAN, NICORANDIL, ALGINATE, FUROSEMIDE, OMEPRAZOLE, HYDROXYZINE PAMOATE. Patient was hospitalized. Patient died on 12/29/2004.

Fabrazyme Side Effects Report #4652526-3
Fabrazyme side effect was reported by a Health Professional from on Apr 18, 2005. Male patient, 83 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, myocardial fibrosis, myocarditis. Fabrazyme dosage: 55 MG Q2WKS IV. During the same period patient was treated with ZANTAC, GLICAZIDE, METFORMIN, AMIODARONE, METOPROLOL TARTRATE, MADOPAR. Patient died on 04/12/2005.

Fabrazyme Side Effects Report #4664798-X
Fabrazyme side effect was reported by a Consumer or non-health professional from on May 04, 2005. Male patient, 83 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, myocarditis, renal impairment. Fabrazyme dosage: 55 MG Q2WKS IV. During the same period patient was treated with ZANTAC, GLICAZIDE, METFORMIN, AMIODARONE, METOPROLOL, MADOPAR. Patient died on 04/12/2005.

Fabrazyme Side Effects Report #5700827-X
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 26, 2008. Male patient, 82 years of age, weighting 138.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, disease progression. Fabrazyme dosage: 65 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5326887-6
Fabrazyme side effect was reported by a Physician from JAPAN on May 01, 2007. Male patient, 80 years of age, weighting 147.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4754375-4
Fabrazyme side effect was reported by a Physician from JAPAN on Aug 16, 2005. Male patient, 78 years of age, weighting 103.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, renal failure acute. Fabrazyme dosage: 47 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, FUROSEMIDE, ASPIRIN, CARVEDILOL, CERNITIN POLLEN, FAMOTIDINE, ETIZOLAM, WARFARIN POTASSIUM. Patient was hospitalized. Patient died on 08/14/2005.

Fabrazyme Side Effects Report #4777568-9
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 08, 2005. Male patient, 78 years of age, weighting 103.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, renal failure acute. Fabrazyme dosage: 47 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, FUROSEMIDE, ASPIRIN, CARVEDILOL, CERNITIN POLLEN, FAMOTIDINE, ETIZOLAM, WARFARIN POTASSIUM. Patient was hospitalized. Patient died on 08/14/2005.

Fabrazyme Side Effects Report #5839281-6
Fabrazyme side effect was reported by a Physician from JAPAN on July 28, 2008. Male patient, 76 years of age, weighting 88.18 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, disease progression, mitral valve prolapse, pneumonia aspiration, tricuspid valve incompetence. Fabrazyme dosage: 40 MG, Q2W, INTRAVENOUS. During the same period patient was treated with PIMOBENDAN, DIURETICS, ACETAMINOPHEN, HYDROXYZINE, SPIRONOLACTONE, CARVEDILOL. Patient was hospitalized. Patient died on 12/02/2007.

Fabrazyme Side Effects Report #5226223-X
Fabrazyme side effect was reported by a Physician from JAPAN on Jan 15, 2007. Female patient, 69 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: azotaemia, cardiac arrest , cardiac failure chronic, condition aggravated, disease recurrence, hypotension, mobility decreased, oedema peripheral, renal failure chronic. Fabrazyme dosage: 50 MG Q2WKS IV. During the same period patient was treated with ASPIRIN, SPIRONOLACTONE, FUROSEMIDE. Patient was hospitalized. Patient died on 08/05/2006.


Fabrazyme Side Effects Report #5132527-1
Fabrazyme side effect was reported by a Physician from JAPAN on Oct 03, 2006. Female patient, 69 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure, cholelithiasis, condition aggravated. Fabrazyme dosage: 50 MG Q2WKS IV. During the same period patient was treated with ALACEPRIL, URSODESOXYCHOLIC ACID, ASPIRIN, SPIRONOLACTONE, FUROSEMIDE, LEVOTHYROXINE, WARFARIN, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5132615-X
Fabrazyme side effect was reported by a Physician from JAPAN on Oct 03, 2006. Female patient, 69 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac arrest , cardiac failure chronic, condition aggravated. Fabrazyme dosage: 50 MG Q2WKS IV. Patient was hospitalized. Patient died on 08/05/2006.

Fabrazyme Side Effects Report #4975609-7
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 30, 2006. Female patient, 69 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure chronic, cholelithiasis, condition aggravated, refusal of treatment by patient. Fabrazyme dosage: 50 MG Q2WKS IV. During the same period patient was treated with ALACEPRIL, URSODESOXYCHOLIC ACID, ASPIRIN, SPIRONOLACTONE, FUROSEMIDE, LEVOTHYROXINE, WARFARIN POTASSIUM, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4630802-8
Fabrazyme side effect was reported by a Health Professional from on Mar 25, 2005. Male patient, 67 years of age, weighting 202.8 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: arthralgia, condition aggravated, joint swelling, loose body in joint, synovial disorder. Fabrazyme dosage: 105 MG Q2WKS IV. During the same period patient was treated with GLYBURIDE, AVANDIA, HYDRODIURIL, TOPROL, SPIRONOLACTONE, ZOCOR, DUONEB, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5694195-X
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 26, 2008. Female patient, 66 years of age, weighting 90.39 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure acute, cardiac hypertrophy, condition aggravated, dilatation ventricular, fabry's disease, gastroenteritis staphylococcal, pneumonia , pulmonary haemorrhage, renal failure acute. Fabrazyme dosage: 40 MG, Q2W, INTRAVENOUS. During the same period patient was treated with BETAMETHASONE. Patient was hospitalized. Patient died on 12/17/2005.


Fabrazyme Side Effects Report #5846131-0
Fabrazyme side effect was reported by a Physician from UNITED STATES on Aug 01, 2008. Male patient, 64 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, supraventricular tachycardia. Fabrazyme dosage: 70 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5102854-2
Fabrazyme side effect was reported by a Physician from JAPAN on Aug 25, 2006. Male patient, 63 years of age, weighting 141.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: azotaemia, condition aggravated, medical device complication, ventricular fibrillation. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ACETAMINOPHEN, BETAMETHASONE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5108639-5
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 07, 2006. Male patient, 63 years of age, weighting 141.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: azotaemia, condition aggravated, implantable defibrillator malfunction, ventricular fibrillation. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ACETAMINOPHEN, BETAMETHASONE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4653856-1
Fabrazyme side effect was reported by a Physician from on Apr 20, 2005. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain , condition aggravated, diarrhoea, intestinal ischaemia, renal failure, vomiting. Fabrazyme dosage: 1 MG/KG Q2WKS IV; 3 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4909812-9
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 26, 2006. Male patient, 59 years of age, weighting 130.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood pressure increased, cardiac ventricular disorder, condition aggravated, deafness, myocardial infarction, nausea , post procedural complication, scar . Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5386006-7
Fabrazyme side effect was reported by a Physician from GERMANY on June 26, 2007. Male patient, 58 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, coronary artery bypass , haemodialysis, hip arthroplasty, renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. Patient died on 01/01/2007.

Fabrazyme Side Effects Report #4565622-6
Fabrazyme side effect was reported by a Health Professional from on Jan 14, 2005. Male patient, 58 years of age, weighting 164.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac disorder, condition aggravated, dyspnoea, nocturnal dyspnoea, oedema peripheral. Fabrazyme dosage: 70 MG Q2WKS, IV. During the same period patient was treated with CELLCEPT, BACTRIM, NEORAL, COUMADIN, LASIX. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4596210-3
Fabrazyme side effect was reported by a Health Professional from on Feb 17, 2005. Male patient, 58 years of age, weighting 164.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac disorder, cardiac valve disease, condition aggravated, dyspnoea exertional, heart valve replacement, oedema peripheral. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with CELLCEPT, BACTRIM, NEORAL, COUMADIN, LASIX, BETAPACE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5244223-0
Fabrazyme side effect was reported by a Physician from UNITED KINGDOM on Jan 31, 2007. Male patient, 56 years of age, weighting 136.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood creatinine increased, brain stem ischaemia, cardiac arrest , coma, condition aggravated, device related infection, encephalopathy, hyperhidrosis, multi-organ failure. Fabrazyme dosage: 1MG/KG Q2WKS; IV. Patient was hospitalized. Patient died on 01/05/2007.

Fabrazyme Side Effects Report #5408278-2
Fabrazyme side effect was reported by a Physician from SLOVENIA on July 24, 2007. Male patient, 56 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure acute, cardiac failure congestive, condition aggravated, mitral valve incompetence. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, ASPIRIN. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #4733824-1
Fabrazyme side effect was reported by a Physician from JAPAN on July 27, 2005. Male patient, 56 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, hypotension. Fabrazyme dosage: 55 MG Q2WKS; IV. During the same period patient was treated with ACETAMINOPHEN, HYDROXYZINE PAMOATE, METHYLPREDNISOLONE SUCCINATE, WARFARIN POTASSIUM, CALCITRIOL, ALLOPURINOL, PRECIPITATED CALCIUM CARBONATE, SENNOSIDE. Patient recovered.

Fabrazyme Side Effects Report #4751541-9
Fabrazyme side effect was reported by a Physician from GERMANY on Aug 11, 2005. Male patient, 56 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, coronary artery stenosis, disease recurrence, myocardial infarction, paraesthesia, renal failure, tachyarrhythmia, temperature intolerance. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with DELIX, ASPIRIN, PLAVIX, NEXIUM, CONCOR, SORTIS. Patient recovered.

Fabrazyme Side Effects Report #5704155-8
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 26, 2008. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure chronic, condition aggravated, mitral valve incompetence. Fabrazyme dosage: 70 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5757566-9
Fabrazyme side effect was reported by a Physician from JAPAN on May 15, 2008. Male patient, 54 years of age, weighting 152.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure chronic, cerebral haemorrhage, condition aggravated, dialysis , mitral valve incompetence, pericardial effusion, renal failure chronic, tricuspid valve incompetence. Fabrazyme dosage: 65 MG, Q2W, INTRAVENOUS; 70 MG Q2W, INTRAVENOUS. During the same period patient was treated with CANDESARTAN CILEXETIL, CARVEDILOL, TRICHLORMETHIAZIDE, PIMOBENDAN, BENIDIPINE HYDROCHLORIDE, ALLOPURINOL, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4865678-7
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2005. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest , condition aggravated, loss of consciousness. Fabrazyme dosage: 70 MG IV. During the same period patient was treated with ASPIRIN, TYLENOL, LIPITOR. Patient died on 12/06/2005.


Fabrazyme Side Effects Report #5286946-3
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 20, 2007. Male patient, 53 years of age, weighting 169.8 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5324705-3
Fabrazyme side effect was reported by a Consumer or non-health professional from JAPAN on Apr 26, 2007. Male patient, 53 years of age, weighting 169.8 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: aortic valve incompetence, bronchitis , cardiac failure, condition aggravated, mitral valve incompetence, mitral valve prolapse, tricuspid valve incompetence. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ASPIRIN, WARFARIN POTASSIUM, ALLOPURINOL, BENIDIPINE HYDROCHLORIDE, METILDIGOXIN, FUROSEMIDE, CANDESARTAN CILEXETIL, CARVEDILOL. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5503483-9
Fabrazyme side effect was reported by a Physician from FRANCE on Oct 16, 2007. Male patient, 52 years of age, weighting 149.9 lb, was diagnosed with fabry's disease, renal transplant and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: asthma , condition aggravated, haemodialysis, hypertension, renal failure, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with PROGRAF, CELLCEPT. Patient recovered.

Fabrazyme Side Effects Report #5713135-8
Fabrazyme side effect was reported by a Physician from JAPAN on Apr 04, 2008. Female patient, 51 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, renal failure. Fabrazyme dosage: 50 MG, Q2W, INTRAVENOUS. During the same period patient was treated with TEMOCAPRIL HYDROCHLORIDE, ALLOPURINOL, ASPIRIN, NITRAZEPAM. Patient recovered.

Fabrazyme Side Effects Report #4679727-2
Fabrazyme side effect was reported by a Consumer or non-health professional from on May 13, 2005. Female patient, 51 years of age, weighting 224.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, convulsion, stress . Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with BENADRYL. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5377931-1
Fabrazyme side effect was reported by a Physician from UNITED STATES on June 18, 2007. Male patient, 50 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: aphonia, carpal tunnel syndrome , condition aggravated, ischaemic stroke, limb injury, pain in extremity, thrombosis. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with COZAAR, PLAVIX, TOPROL, LEXAPRO, LASIX, CYCLOSPORINE, CELLCEPT, PREDNISONE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5455154-5
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 04, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5477785-9
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 18, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, ventricular extrasystoles. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5477786-0
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 18, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, disease progression, ventricular extrasystoles. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5477788-4
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 18, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, ventricular extrasystoles. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5930346-7
Fabrazyme side effect was reported by a Physician from JAPAN on Oct 09, 2008. Female patient, 48 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: brain natriuretic peptide increased, cardiac failure, condition aggravated, electrocardiogram abnormal, heart rate decreased, mitral valve incompetence, ventricular extrasystoles. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ENALAPRIL MALEATE, ENALAPRIL MALEATE, CARVEDILOL, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4565629-9
Fabrazyme side effect was reported by a Health Professional from on Jan 14, 2005. Male patient, 47 years of age, weighting 131.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4596193-6
Fabrazyme side effect was reported by a Physician from on Feb 21, 2005. Female patient, 47 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain , condition aggravated, convulsion, dyspnoea, gastrointestinal disorder, hypertension, hypertensive crisis, treatment noncompliance, unevaluable event. Fabrazyme dosage: 1.1 MG/KG Q2WKS IV. During the same period patient was treated with WELLBUTRIN, NORVASC, CATAPRES, ATENOLOL. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4547288-4
Fabrazyme side effect was reported by a Physician from on Dec 22, 2004. Female patient, 46 years of age, weighting 130.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: arthralgia, body temperature increased, condition aggravated, fabry's disease, infusion related reaction, pain , paraesthesia. Fabrazyme dosage: 59 MG Q2WKS IV. During the same period patient was treated with BENADRYL, TYLENOL. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4829989-3
Fabrazyme side effect was reported by a Physician from JAPAN on Nov 02, 2005. Male patient, 46 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, fabry's disease, haemodialysis, renal failure chronic. Fabrazyme dosage: 55 MG Q2WKS IV. During the same period patient was treated with ACE INHIBITOR, ANGIOTENSIN RECEPTOR BLOCKER. Patient recovered.

Fabrazyme Side Effects Report #4838568-3
Fabrazyme side effect was reported by a Physician from UNITED STATES on Nov 15, 2005. Male patient, 46 years of age, weighting 211.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, rectal haemorrhage. Fabrazyme dosage: 70 MG IV. During the same period patient was treated with DILANTIN, TEGRETOL, PENICILLIN V POTASSIUM, WARFARIN, LISINOPRIL. Patient recovered.

Fabrazyme Side Effects Report #4884556-0
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 12, 2006. Male patient, 46 years of age, weighting 211.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, rectal haemorrhage. Fabrazyme dosage: 70 MG IV. During the same period patient was treated with DILANTIN, TEGRETOL, PENICILLIN V POTASSIUM, WARFARIN, LISINOPRIL. Patient recovered.

Fabrazyme Side Effects Report #4652972-8
Fabrazyme side effect was reported by a Health Professional from on Apr 21, 2005. Male patient, 44 years of age, weighting 135.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, fabry's disease. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with TEGRETOL, PREDNISONE, SANDIMMUNE, METOCLOPRAMIDE, ZOFRAN, XANAX, RESTORIL, PLENDIL. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4663698-9
Fabrazyme side effect was reported by a Health Professional from on May 12, 2005. Male patient, 44 years of age, weighting 135.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: angina pectoris, condition aggravated, dyspnoea, fabry's disease, headache , heart rate increased, pain , shoulder pain, temperature regulation disorder. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with TEGRETOL, PREDNISONE, SANDIMMUNE, METOCLOPRAMIDE, ZOFRAN, XANAX, RESTORIL, PLENDIL. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4746176-8
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2005. Male patient, 44 years of age, weighting 209.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, renal failure chronic, renal transplant. Fabrazyme dosage: 90 MG Q2WKS IV. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #4748477-6
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Aug 11, 2005. Male patient, 44 years of age, weighting 209.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, renal failure chronic. Fabrazyme dosage: 88 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5715790-5
Fabrazyme side effect was reported by a Physician from FRANCE on Apr 08, 2008. Female patient, 43 years of age, weighting 116.8 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, depression , inflammation, skin nodule, tremor. Fabrazyme dosage: unknown. Patient recovered.

Fabrazyme Side Effects Report #4583512-X
Fabrazyme side effect was reported by a Physician from on Jan 13, 2005. Male patient, 43 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, condition aggravated, liver function test abnormal, renal function test abnormal. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ACE INHIBITORS. Patient recovered.

Fabrazyme Side Effects Report #4615956-1
Fabrazyme side effect was reported by a Physician from on Mar 07, 2005. Male patient, 43 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, condition aggravated, gamma-glutamyltransferase increased, hepatic fibrosis, liver function test abnormal. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ACE INHIBITORS. Patient recovered.

Fabrazyme Side Effects Report #5119481-3
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Sept 15, 2006. Female patient, 42 years of age, weighting 136.0 lb, was diagnosed with fabry's disease, pain  and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, condition aggravated, fabry's disease, hepatic enzyme increased, hepatocellular damage, hypotension, nephropathy toxic, overdose, rebound hypertension. Fabrazyme dosage: 65 MG Q2WKS IV. During the same period patient was treated with TYLENOL, DIOVAN, HYDROCHLOROTHIAZDE, TEGRETOL, ASPIRIN, IRON SUPPLEMENT. Patient recovered.

Fabrazyme Side Effects Report #5681124-8
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 12, 2008. Male patient, 41 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, delirium, dizziness , ischaemic stroke, psychotic disorder , vascular calcification. Fabrazyme dosage: 50 MG, Q2W, INTRAVENOUS. During the same period patient was treated with CELESTAMINE, DICLOFENAC, LACTOMIN, SEVELAMER HYDROCHLORIDE, CARBAMAZEPINE, PRECIPITATED CALCIUM CARBONATE, FAMOTIDINE. Patient was hospitalized. Patient died.

Fabrazyme Side Effects Report #5341538-2
Fabrazyme side effect was reported by a Physician from GERMANY on May 15, 2007. Female patient, 40 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: brain stem ischaemia, condition aggravated, diplopia, multiple sclerosis , transient ischaemic attack, vision blurred. Fabrazyme dosage: unknown. During the same period patient was treated with INTERFERON, AMLODIPINE, METHOTREXATE, JODETTEN, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5708903-2
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 03, 2008. Male patient, 39 years of age, weighting 149.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: activities of daily living impaired, asthma , condition aggravated. Fabrazyme dosage: 68 MG, Q2W, INTRAVENOUS. Patient recovered.

Fabrazyme Side Effects Report #5731109-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on Apr 25, 2008. Male patient, 39 years of age, weighting 158.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: asthma , chest pain , chills, condition aggravated, infusion related reaction, vomiting. Fabrazyme dosage: 70 MG, Q2W, INTRAVENOUS. During the same period patient was treated with HYDROXYZINE. Patient recovered.

Fabrazyme Side Effects Report #6016902-9
Fabrazyme side effect was reported by a Physician from FRANCE on Dec 08, 2008. Male patient, 39 years of age, weighting 130.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: angioedema, blood pressure increased, bronchospasm, cerebrovascular accident, chest discomfort, chills, condition aggravated, cough, face oedema. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with IRBESARTAN, ORDRIK, ATARAX, ACETAMINOPHEN, PREDNISONE. Patient recovered.


Fabrazyme Side Effects Report #6035235-8
Fabrazyme side effect was reported by a Physician from FRANCE on Dec 31, 2008. Male patient, 39 years of age, weighting 130.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: angioedema, blood pressure increased, bronchospasm, cerebrovascular accident, condition aggravated, face oedema, infusion related reaction, oxygen saturation decreased, renal failure. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with IRBESARTAN, ODRIK, ATARAX, ACETAMINOPHEN, CORTANCYL. Patient recovered.

Fabrazyme Side Effects Report #6094240-6
Fabrazyme side effect was reported by a Physician from FRANCE on Feb 18, 2009. Male patient, 39 years of age, weighting 130.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: angioedema, antibody test positive, blister, blood pressure increased, bronchospasm, cerebrovascular accident, complement factor increased, condition aggravated, cough. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with IRBESARTAN, TRANDOLAPRIL, ATARAX, PARACETAMOL, PREDNISONE. Patient recovered.

Fabrazyme Side Effects Report #5279893-4
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 12, 2007. Male patient, 37 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, peritoneal dialysis, renal failure chronic, renal transplant, renal vein thrombosis, transplant failure. Fabrazyme dosage: 60 MG Q2WKS IV. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #4855151-4
Fabrazyme side effect was reported by a Physician from UNITED STATES on Nov 30, 2005. Male patient, 37 years of age, weighting 198.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: back pain , cauda equina syndrome, condition aggravated, intervertebral disc protrusion, sciatica . Fabrazyme dosage: 90 MG Q2WKS IV. During the same period patient was treated with PROZAC, TOPAMAX, OXYCONTIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5261648-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on Feb 26, 2007. Male patient, 36 years of age, weighting 175.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood pressure increased, condition aggravated, dialysis , fabry's disease, haemoglobin decreased, microalbuminuria, neuropathy, pain , pain in extremity. Fabrazyme dosage: 80 MG Q2WKS IV. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.

Fabrazyme Side Effects Report #5218704-X
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 08, 2007. Male patient, 35 years of age, weighting 215.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: appendicitis , colitis, condition aggravated, depression , enlarged uvula, epilepsy , erythema, face oedema. Fabrazyme dosage: unknown. During the same period patient was treated with LEXAPRO, PLAVIX, AMITRIPTYLINE, FOSINOPRIL, MAXZIDE, XANAX. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5105230-1
Fabrazyme side effect was reported by a Physician from UNITED STATES on Aug 29, 2006. Male patient, 35 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain , condition aggravated, convulsion, depression , diarrhoea, erythema, face oedema, impaired work ability. Fabrazyme dosage: 105 MG IV. During the same period patient was treated with LEXAPRO, PLAVIX, AMITRIPTYLINE, FOSINOPRIL, MAXZIDE, XANAX. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5123148-5
Fabrazyme side effect was reported by a Physician from UNITED STATES on Sept 22, 2006. Male patient, 35 years of age, weighting 185.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, dialysis , haemodialysis, hyponatraemia, oedema peripheral, peritoneal dialysis, renal impairment. Fabrazyme dosage: 85 MG Q2WKS IV. During the same period patient was treated with TYLENOL, LASIX, LISINOPRIL, LIPITOR, NEURONTIN. Patient recovered.

Fabrazyme Side Effects Report #4907187-2
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 24, 2006. Male patient, 35 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain , condition aggravated, convulsion, depression , diarrhoea, erythema, face oedema, impaired work ability, localised oedema. Fabrazyme dosage: 105 MG IV. During the same period patient was treated with LEXAPRO, PLAVIX, AMITRIPTYLINE, FOSINOPRIL, MAXZIDE, XANAX. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5388747-4
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2007. Male patient, 34 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, renal failure. Fabrazyme dosage: 55 MG Q2WKS IV. Patient was hospitalized. Patient recovered.


Fabrazyme Side Effects Report #5302366-7
Fabrazyme side effect was reported by a Physician from JAPAN on Apr 02, 2007. Male patient, 32 years of age, weighting 112.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, haemodialysis, renal failure, renal transplant. Fabrazyme dosage: 50 MG Q2WKS IV. During the same period patient was treated with CARBAMAZEPINE, AMLODIPINE BESYLATE, MYCOPHENOLATE MOFETIL, TACROLIMUS HYDRATE, ASPIRIN. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5679683-4
Fabrazyme side effect was reported by a Health Professional from UNITED KINGDOM on Mar 07, 2008. Female patient, 31 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: carpal tunnel syndrome , condition aggravated, fabry's disease, oedema peripheral, pain in extremity, pre-eclampsia, pregnancy . Fabrazyme dosage: 55 MG, Q2W, INTRAVENOUS. Patient recovered.

Fabrazyme Side Effects Report #4732457-0
Fabrazyme side effect was reported by a Physician from UNITED STATES on July 18, 2005. Male patient, 14 years of age, weighting 335.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: benign intracranial hypertension, condition aggravated, diplopia, headache , seborrhoeic dermatitis, sinus disorder. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with DOXYCYCLINE, MOTRIN, NEURONTIN, NEXIUM, ZYRTEC, SINGULAIR, PULMICORT. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5362847-7
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on June 07, 2007. Female patient, 13 years of age, weighting 95.00 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain , back pain , condition aggravated, constipation , fabry's disease, no therapeutic response. Fabrazyme dosage: 35 MG Q2WKS IV. During the same period patient was treated with IBUPROFEN, BENADRYL, PREDNISONE, OXYCODONE. Patient was hospitalized. Patient recovered.